ICU Medical, Inc. (NASDAQ:ICUI) Short Interest Down 9.0% in September

ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) was the target of a large drop in short interest during the month of September. As of September 30th, there was short interest totalling 756,400 shares, a drop of 9.0% from the September 15th total of 831,100 shares. Based on an average trading volume of 298,300 shares, the short-interest ratio is currently 2.5 days. Approximately 3.4% of the company's shares are short sold.

Analyst Ratings Changes

ICUI has been the subject of a number of research reports. Raymond James increased their price target on shares of ICU Medical from $158.00 to $190.00 and gave the stock an "outperform" rating in a research note on Thursday, September 12th. Jefferies Financial Group initiated coverage on ICU Medical in a research report on Monday. They issued a "hold" rating and a $183.00 target price for the company. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research note on Thursday, October 10th. StockNews.com raised ICU Medical from a "hold" rating to a "buy" rating in a research note on Thursday, September 12th. Finally, KeyCorp increased their price objective on ICU Medical from $147.00 to $198.00 and gave the stock an "overweight" rating in a report on Tuesday. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $170.25.

Insider Buying and Selling at ICU Medical

In other news, VP Virginia Ruth Sanzone sold 2,050 shares of the stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $144.11, for a total transaction of $295,425.50. Following the completion of the sale, the vice president now directly owns 4,482 shares in the company, valued at approximately $645,901.02. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, VP Virginia Ruth Sanzone sold 2,050 shares of the company's stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $144.11, for a total transaction of $295,425.50. Following the completion of the transaction, the vice president now owns 4,482 shares in the company, valued at $645,901.02. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Vivek Jain sold 12,000 shares of the firm's stock in a transaction on Friday, August 16th. The stock was sold at an average price of $156.04, for a total value of $1,872,480.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at $16,320,691.72. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 40,552 shares of company stock worth $6,679,322. 6.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Motco bought a new stake in shares of ICU Medical during the first quarter valued at approximately $29,000. Innealta Capital LLC bought a new stake in shares of ICU Medical in the 2nd quarter worth $32,000. GAMMA Investing LLC raised its stake in shares of ICU Medical by 75.1% in the first quarter. GAMMA Investing LLC now owns 310 shares of the medical instruments supplier's stock worth $33,000 after purchasing an additional 133 shares during the last quarter. Hexagon Capital Partners LLC lifted its holdings in shares of ICU Medical by 162.7% during the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier's stock valued at $36,000 after purchasing an additional 122 shares in the last quarter. Finally, EntryPoint Capital LLC boosted its position in shares of ICU Medical by 731.5% during the first quarter. EntryPoint Capital LLC now owns 449 shares of the medical instruments supplier's stock valued at $48,000 after buying an additional 395 shares during the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.

ICU Medical Stock Up 2.4 %

Shares of ICU Medical stock traded up $4.33 during midday trading on Wednesday, hitting $183.83. The company had a trading volume of 166,184 shares, compared to its average volume of 281,082. ICU Medical has a 52-week low of $78.28 and a 52-week high of $188.53. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 2.41. The stock has a market capitalization of $4.48 billion, a P/E ratio of -75.18 and a beta of 0.66. The company has a 50 day moving average of $167.70 and a 200 day moving average of $130.83.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.56. The firm had revenue of $596.50 million during the quarter, compared to the consensus estimate of $556.64 million. ICU Medical had a positive return on equity of 5.01% and a negative net margin of 3.07%. The company's revenue was up 8.6% on a year-over-year basis. During the same period last year, the company earned $1.58 earnings per share. On average, equities analysts predict that ICU Medical will post 3.76 earnings per share for the current fiscal year.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.